The influence of local instillation of fusidic acid on the development of microbial complications after lung resection

Journal of Chemotherapy

Volumn 18, Issue 3, 2006, Pages 285-292

  Baltayiannis, N ^a   Markogiannakis, A ^b   Sfyridis, P ^a   Manolis, E N ^b   Anagnostopoulos, D ^a   Bolanos, N ^a   Hatzimichalis, A ^a   Tsakris, A ^b  

^a METAXA CANCER HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

Bronchopleural fistula; Empyema; Local instillation; Pneumonectomy; Pneumonia; Wound infection

Indexed keywords

CEFUROXIME; FUSIDIC ACID;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; BRONCHOPLEURAL FISTULA; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG INSTILLATION; EMPYEMA; FEMALE; HUMAN; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MICROORGANISM DETECTION; PNEUMONIA; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; REVIEW; RISK FACTOR; SURGICAL INFECTION; THORACOTOMY; THORAX SURGERY;

EID: 33746253136     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2006.18.3.285     Document Type: Review

References (25)

1. Abbas Ael-S, Deschamps C. Postpneumonectomy empyema. Curr Opin Pulmonary Med 2002;8:327-33.
2. Massard G, Lyons G, Wihlm JM, et al. Early and longterm results after completion pneumonectomy. Ann Thorac Surg 1995;59:196-200.
3. Athanassiadi K, Vassilikos K, Misthos P, et al. Late postpneumonectomy bronchopleural fistula. Thorac Cardiovac Surg 2004; 52:298-301.
4. Schneiter D, Cassina P, Korom S, et al. Accelerated treatment for early and late postpneumonectomy empyema. Ann Thorac Surg 2001;72:1668-72.
5. Wain JC. Management of late postpneumonectomy empyema and bronchopleural fistula. Chest Surg Clinic 1996;6:529-41.
6. Hollaus PH, Huber M, Lax F, Wurnig P, Bohm G, Pridun NS. Closure of bronchopleural fistula after pneumonectomy with a pedicled intercostal muscle flap. Eur J Cardio-thorac Surg 1999;16:181-6.
7. Jadczuck E. Postpneumonectomy empyema. Eur J Cardio-thorac Surg 1998;14:123-6.
8. Gharagozloo F, Trachiotis G, Wolfe A, Dubree KJ, Cox JL. Pleural space irrigation and modified Clagett procedure for the treatment of early postpneumonectomy empyema. J Thorac Cardiovasc Surg 1998;116:943-8.
9. Kacprzak G, Marciniak M, Addae-Boateng E, Kolodziej J, Pawelczyk K. Causes and management of postpneumonectomy empyemas: our experience. Eur J Cardio-thorac Surg 2004;26:498-502.
10. Miller JD, Nemni J, Simone C, Young JE, Bennett WF, Urschel JD. Prophylactic intracavitary (pneumonectomy space) antibiotic instillation: a comparative study. Ann Thorac Cardiovasc Surg 2001;7:14-6.
11. Whitby M. Fusidic acid in the treatment of methicillin-resistant Staphylococcus aureus. Intern J Antimicrob Agents 1999; 12 (Suppl 2):S67-S71.
12. Collignon P, Turnidge J. Fusidic acid in vitro activity. Intern J Antimicrob Agents 1999; 12 (Suppl 2):S45-S58.
13. Leclercq R, Bismuth R, Casin I, et al. In vitro activity of fusidic acid against streptococci isolated from skin and soft tissue infections. J Antimicrob Chemother 2000; 45:27-9.
14. Whitby M. Fusidic acid in septicemia and endocarditis. Intern J Antimicrob Agents 1999; 12 (Suppl 2):S17-S22.
15. American Joint Committee on Cancer. Staging of cancer forms. 3rd ed. New York: JB Lippincott 1988.
16. Koneman EW, Allen SD, Janda WM, Schreckenberger PC, Winn WC. Color Atlas and Textbook of Diagnostic Microbiology, 5th Ed. Philadelphia: Lippincott, 1997.
17. National Committee for Clinical Laboratory Standards (NCCLS). Performance standards for antimicrobial disk susceptibility tests. Approved standard M2-A7. Wayne,: NCCLS, 2001.
18. Juhl B, Frost N. A comparison between measured and calculated changes in the lung function after operation for pulmonary cancer. Acta Anaesthesiol Scand 1975;57(Suppl):39-45.
19. Garrett ER, Richard AJ. Kinetics and mechanisms of drug action on microorganisms XX. Integrated receptor site model rationalizing observed microbial rate dependencies on drug concentration and microbial kinetics affected by sodium fusidate. J Pharm Sci 1974;63:884-94.
20. Turnidge J. Fusidic acid pharmacology, pharmacokinetics and pharmacodynamics. Intern J Antimicrob Agents 1999; 12(Suppl 2):S23-S34.
21. Kentall SW, Antrum RM, Ramsden CH, Kester RC. A study of fucidin uptake in ischaemic tissues. Drugs Exp Clin Res 1988;14:655-7.
22. de Louvois J, Hurley R. Inactivation of penicillin by purulent exudates. Br Med J 1977: 1(6067):998-1000.
23. Morris SD, Rycroft RJ, White IR, Wakelin SH, McFadden JP. Comparative frequency of positive allergic patch test reactions to topical antibiotics. Br J Dermatol 2002;146:1047-51.
24. Christiansen K. Fusidic acid adverse drug reactions. Intern J Antimicrob Agents 1999; 12(Suppl 2):S3-S9.
25. Nagaev I, Bjorkman J, Andersson DI, Hughes D. Biological cost and compensatory evolution in fusidic acid-resistant Staphylococcus aureus. Mol Microbiol 2001;40:433-9.